Glucocorticoid eye drops inhibit growth in the newborn rabbit.

AIM To investigate if postoperative treatment with dexamethasone eye drops has the capacity to affect longitudinal growth in newborn rabbits. METHODS Thirty-four male and female rabbits had clear lens extraction performed in one eye at 3 wk of age and were then treated either intensively (group 1) or less intensively (group 2) with de-escalating doses of dexamethasone eye drops for 8 wk (average doses 0.27 and 0.10 mg/kg body weight/day, respectively). The control group (group 3) received vehicle eye drops only. Body weight and crown-rump length were recorded every week. After 8 wk of treatment, all rabbits were killed and the left femur was measured. RESULTS Rabbits treated with dexamethasone eye drops gained weight slower (711+/-42 and 989+/-153 g weight increase for groups 1 and 2, respectively) than control animals (group 3; 1224+/-87 g weight increase; p<0.001 vs group 1, p<0.01 vs group 2). Longitudinal growth, determined as increase in crown-rump and femur lengths, was impaired by dexamethasone eye drops in a dose-dependent way. Crown-rump length increased by 8.25+/-0.86, 10.90+/-1.19 and 15.35+/-1.31 cm in groups 1, 2 and 3, respectively (p<0.001 for all comparisons). At endpoint, i.e. after 8 wk of treatment, the average femur length was 6.36+/-0.21, 7.39+/-0.27 and 8.37+/-0.28 cm in groups 1, 2 and 3, respectively (p<0.001 for all comparisons). CONCLUSION Dexamethasone, administered topically as eye drops, has systemic effects and impairs longitudinal growth in young rabbits. Therefore, we propose that growth should be closely monitored in all children intensively treated with glucocorticoid eye drops.

[1]  A. Vasavada,et al.  Visual axis opacification after AcrySof intraocular lens implantation in children , 2004, Journal of cataract and refractive surgery.

[2]  P. Rabiah Frequency and predictors of glaucoma after pediatric cataract surgery. , 2004, American journal of ophthalmology.

[3]  D. Chrysis,et al.  Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. , 2003, The Journal of endocrinology.

[4]  A. Lundvall,et al.  Outcome after treatment of congenital unilateral cataract. , 2002, Acta ophthalmologica Scandinavica.

[5]  H. Uhthoff,et al.  Review of growth plate closure compared with age at sexual maturity and lifespan in laboratory animals. , 2002, Contemporary topics in laboratory animal science.

[6]  B. Chauhan,et al.  Timolol Concentrations in Rat Ocular Tissues and Plasma After Topical and Intraperitoneal Dosing , 2002, Journal of glaucoma.

[7]  C. McGhee,et al.  Locally Administered Ocular Corticosteroids , 2002, Drug safety.

[8]  G. Williams,et al.  Glucocorticoids, Thyroid Hormone and Growth Hormone Interactions: Implications for the Growth Plate , 2002, Hormone Research in Paediatrics.

[9]  K. Dickstein,et al.  Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. , 2001, American journal of ophthalmology.

[10]  J. Baron,et al.  Catch-Up Growth Is Associated with Delayed Senescence of the Growth Plate in Rabbits , 2001, Pediatric Research.

[11]  I. Schweitzer,et al.  Antiglaucoma Medication and Clinical Depression , 2001, The Australian and New Zealand journal of psychiatry.

[12]  S. Szefler,et al.  Pharmacokinetics of intranasal corticosteroids. , 2001, The Journal of allergy and clinical immunology.

[13]  J. Baraniuk,et al.  The linear relationship between changes in childhood growth velocity and topical glucocorticoid dose. , 2001, Allergy and asthma proceedings.

[14]  N. Lane An update on glucocorticoid-induced osteoporosis. , 2001, Rheumatic diseases clinics of North America.

[15]  Y. Sawada,et al.  Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[16]  D. Allen Systemic effects of intranasal steroids: an endocrinologist's perspective. , 2000, The Journal of allergy and clinical immunology.

[17]  O. Mehls,et al.  Suppression of growth plate chondrocyte proliferation by corticosteroids , 2000, Pediatric Nephrology.

[18]  D. Allen,et al.  Do intranasal corticosteroids affect childhood growth? , 2000, Allergy.

[19]  E. Meltzer,et al.  Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. , 2000, Pediatrics.

[20]  C. Zetterström,et al.  Complications after early surgery for congenital cataracts. , 1999, Acta ophthalmologica Scandinavica.

[21]  D. Stager,et al.  The critical period for surgical treatment of dense congenital unilateral cataract. , 1996, Investigative ophthalmology & visual science.

[22]  J. Leavitt,et al.  Asthma caused by topical application of ketorolac. , 1996, Ophthalmology.

[23]  S. Holgate,et al.  Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. , 1995, American journal of respiratory and critical care medicine.

[24]  J. Rootman,et al.  Ocular pharmacokinetics of subconjunctivally administered cyclosporine in the rabbit. , 1991, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[25]  J. Dutton,et al.  Visual rehabilitation of aphakic children. , 1990, Survey of ophthalmology.

[26]  G. Novack,et al.  Ophthalmic beta-blockers since timolol. , 1987, Survey of ophthalmology.

[27]  E. Palmer,et al.  Plasma timolol in glaucoma patients. , 1984, Ophthalmology.

[28]  D J Baylink,et al.  Glucocorticoid-induced osteoporosis. , 1983, The New England journal of medicine.

[29]  Pressman Sh,et al.  Pediatric aphakic glaucoma. , 1983 .

[30]  H. Leibowitz,et al.  Management of inflammation in the cornea and conjunctiva. , 1980, Ophthalmology.